Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 211284 / DOSAGE - TABLET;ORAL - 300MG;300MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| LAMIVUDINE(UNII: 2T8Q726O95) (LAMIVUDINE - UNII:2T8Q726O95) | LAMIVUDINE | 300mg |
| TENOFOVIR DISOPROXIL FUMARATE(UNII: OTT9J7900I) (TENOFOVIR ANHYDROUS - UNII:W4HFE001U5) | TENOFOVIR DISOPROXIL FUMARATE | 300mg |
Inactive Ingredients
| Ingredient Name | CELLTRION, INC. |
|---|---|
| CROSCARMELLOSE SODIUM(M28OL1HH48) | |
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | |
| POWDERED CELLULOSE(SMD1X3XO9M) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| TITANIUM DIOXIDE(15FIX9V2JP) |
